Gilmore R D, Mbow M L
Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Fort Collins, Colorado 80522, USA.
Infect Immun. 1999 Oct;67(10):5463-9. doi: 10.1128/IAI.67.10.5463-5469.1999.
Active immunization with Escherichia coli-expressed recombinant outer surface protein C (OspC) of Borrelia burgdorferi has been demonstrated to confer protection against a tick-transmitted infection on laboratory animals. A previous study in this laboratory showed that OspC antibody raised against a denatured immunogen isolated from B. burgdorferi cells failed to provide protective immunity. Therefore, to determine whether the protective epitope of the recombinant antigen was sensitive to denaturation, recombinant OspC preparations were subjected to heat and chemical treatments prior to animal immunization. Following seroconversion to OspC, the animals were challenged with an infectious dose of B. burgdorferi B31 by tick bite. Whereas mice immunized with a soluble, nondenatured form continued to show protection rates close to 100%, mice that had been immunized with denatured antigen were not protected. Furthermore, mice that were immunized with an insoluble (rather than a soluble), nondenatured form of the recombinant OspC showed a protection rate of only 40%. Protective epitope localization experiments showed that either the amino or the carboxy end of the recombinant protein was required to react with a protective OspC-specific monoclonal antibody. The data from these experiments demonstrate that a conformational organization of the protein is essential for the protective capability of the strain B31 OspC immunogen.
用大肠杆菌表达的伯氏疏螺旋体重组外表面蛋白C(OspC)进行主动免疫已被证明能使实验动物免受蜱传播感染。本实验室先前的一项研究表明,针对从伯氏疏螺旋体细胞中分离出的变性免疫原产生的OspC抗体不能提供保护性免疫。因此,为了确定重组抗原的保护性表位是否对变性敏感,在动物免疫前对重组OspC制剂进行了加热和化学处理。在血清转化为OspC后,通过蜱叮咬用感染剂量的伯氏疏螺旋体B31攻击动物。用可溶性、非变性形式免疫的小鼠继续显示接近100%的保护率,而用变性抗原免疫的小鼠则没有得到保护。此外,用重组OspC的不溶性(而非可溶性)、非变性形式免疫的小鼠显示的保护率仅为40%。保护性表位定位实验表明,重组蛋白的氨基端或羧基端需要与保护性OspC特异性单克隆抗体反应。这些实验的数据表明,蛋白质的构象组织对于菌株B31 OspC免疫原的保护能力至关重要。